Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Mirja Rotinen
Observed name:
Rotinen, Mirja
Institutions:
Universidad Pública de Navarra (UPNA),
Navarre Institute of Health Research
Observed institutions:
Cedars-Sinai Medical Center,
Universidad Pública de Navarra (UPNA),
Navarre Institute of Health Research,
Universidad de Navarra
ORCID:
0000-0002-0755-8360
Observed ORCID:
0000-0002-0755-8360
OpenAlex ID:
A5030762025
Large Oncosomes in Human Prostate Cancer Tissues and in the Circulation of Mice with Metastatic Disease
2012
·
Dolores Di Vizio
, Matteo Morello
, et al.
·
American Journal Of Pathology
·
475
ONECUT2 Is a Targetable Master Regulator of Lethal Prostate Cancer That Suppresses the Androgen Axis
2018
·
Mirja Rotinen
, Sungyong You
, et al.
·
Nature Medicine
·
208
Emerin Deregulation Links Nuclear Shape Instability to Metastatic Potential
2018
·
Mariana Reis-Sobreiro
, Jie-Fu Chen
, et al.
·
Cancer Research
·
82
PDF
27-Hydroxycholesterol Impairs Plasma Membrane Lipid Raft Signaling as Evidenced by Inhibition of IL6–JAK–STAT3 Signaling in Prostate Cancer Cells
2020
·
Shweta Dambal
, Mahmoud Alfaqih
, et al.
·
Molecular Cancer Research
·
61
ONECUT2 acts as a lineage plasticity driver in adenocarcinoma as well as neuroendocrine variants of prostate cancer
2024
·
Chen Qian
, Qian Yang
, et al.
·
Nucleic Acids Research
·
57
Estradiol induces type 8 17β-hydroxysteroid dehydrogenase expression: crosstalk between estrogen receptor α and C/EBPβ
2008
·
Mirja Rotinen
, Jon Celay
, et al.
·
Journal of Endocrinology
·
29
PDF
Targeting Key Players of Neuroendocrine Differentiation in Prostate Cancer
2023
·
Irene Zamora
, Michael R. Freeman
, et al.
·
International Journal of Molecular Sciences
·
21
PDF
Changes in Gene Expression Profiling of Apoptotic Genes in Neuroblastoma Cell Lines upon Retinoic Acid Treatment
2013
·
Jon Celay
, Idoia Blanco
, et al.
·
PLoS ONE
·
19
PDF
Type 10 17β-hydroxysteroid dehydrogenase expression is regulated by C/EBPβ in HepG2 cells
2010
·
Mirja Rotinen
, Joaquín Villar
, et al.
·
The Journal of Steroid Biochemistry and Molecular Biology
·
19
Transcriptional regulation of the human type 8 17β-hydroxysteroid dehydrogenase gene by C/EBPβ
2007
·
Joaquín Villar
, Jon Celay
, et al.
·
The Journal of Steroid Biochemistry and Molecular Biology
·
19
PDF
ONECUT2 is a druggable driver of luminal to basal breast cancer plasticity
2024
·
Irene Zamora
, Mirian Gutiérrez
, et al.
·
Cellular Oncology
·
11
Regulation of 17β-hydroxysteroid dehydrogenases in cancer: regulating steroid receptor at pre-receptor stage
2012
·
Mirja Rotinen
, Joaquín Villar
, et al.
·
Journal of Physiology and Biochemistry
·
11
Transcriptional regulation of type 11 17β-hydroxysteroid dehydrogenase expression in prostate cancer cells
2011
·
Mirja Rotinen
, Joaquín Villar
, et al.
·
Molecular and Cellular Endocrinology
·
10
Actionable Driver Events in Small Cell Lung Cancer
2023
·
Mirian Gutiérrez
, Irene Zamora
, et al.
·
International Journal of Molecular Sciences
·
8
PDF
ONECUT2 reprograms neuroendocrine fate and is an actionable therapeutic target in small cell lung cancer
2025
·
Mirian Gutiérrez
, Irene Zamora
, et al.
·
Molecular Medicine
·
4
PDF
Scaffold attachment factor B1 regulates androgen degradation pathways in prostate cancer.
2021
·
Julie Suan-Wei Yang
, Chen Qian
, et al.
·
Europe PMC (PubMed Central)
·
4
Meeting report: Metastasis Research Society (MRS) 17th Biennial conference and associated Young Investigator Satellite Meeting (YISM) on cancer metastasis
2019
·
Thomas Beadnell
, Lucia Borriello
, et al.
·
Clinical & Experimental Metastasis
·
2
ONECUT2: a validated drug target and lineage plasticity driver in prostate cancer and other malignancies
2025
·
Michael R Freeman
, Lillian M Perez
, et al.
·
Endocrine Related Cancer
·
1
ONECUT2 as a new therapeutic target in androgen receptor-indifferent prostate cancer
2019
·
Michael R. Freeman
, Mirja Rotinen
, et al.
·
Translational Cancer Research
·
1
PDF
Abstract 4302: ONECUT2 activates diverse resistance drivers of androgen receptor-independent heterogeneity in prostate cancer
2024
·
Chen Qian
, Qian Yang
, et al.
·
Cancer Research
Figure S4 from 27-Hydroxycholesterol Impairs Plasma Membrane Lipid Raft Signaling as Evidenced by Inhibition of IL6–JAK–STAT3 Signaling in Prostate Cancer Cells
2023
·
Shweta Dambal
, Mahmoud Alfaqih
, et al.
PDF
Figure S2 from 27-Hydroxycholesterol Impairs Plasma Membrane Lipid Raft Signaling as Evidenced by Inhibition of IL6–JAK–STAT3 Signaling in Prostate Cancer Cells
2023
·
Shweta Dambal
, Mahmoud Alfaqih
, et al.
Supplemental Materials and Methods, Supplementary Tables 1 and 2 from 27-Hydroxycholesterol Impairs Plasma Membrane Lipid Raft Signaling as Evidenced by Inhibition of IL6–JAK–STAT3 Signaling in Prostate Cancer Cells
2023
·
Shweta Dambal
, Mahmoud Alfaqih
, et al.
PDF
Figure S7 from 27-Hydroxycholesterol Impairs Plasma Membrane Lipid Raft Signaling as Evidenced by Inhibition of IL6–JAK–STAT3 Signaling in Prostate Cancer Cells
2023
·
Shweta Dambal
, Mahmoud Alfaqih
, et al.
Figure S1 from 27-Hydroxycholesterol Impairs Plasma Membrane Lipid Raft Signaling as Evidenced by Inhibition of IL6–JAK–STAT3 Signaling in Prostate Cancer Cells
2023
·
Shweta Dambal
, Mahmoud Alfaqih
, et al.
PDF
Show more works
View as search
Works count:
54
Citation count:
1,042
H-index:
11
I10-index:
13
Year
Topic
Type